Skip to Main Content

Paper Details

PTEN Loss Mediates Clinical Cross-Resistance to CDK4/6 and PI3Kα Inhibitors in Breast Cancer.
Cancer Discov
134
2020
AKT, Breast Cancer, CDK2, CDK4, CDK4/6, ER, PI3K, PTEN, RB, advanced breast cancer, breast cancer, breast cancer cells, letrozole, p27, patient, patients, ribociclib, tumors
Author NameAffiliation
Aditya BardiaMassachusetts General Hospital Cancer Center and Harvard Medical School
Cyril H BenesMassachusetts General Hospital Cancer Center and Harvard Medical School
  • 1 - 2

Datasets

Release 1.2